2m 2m 2m 2m 2m 2m 2m
ALTO NEURO (ANRO)
NYSE
$34.54+$0.26 (+0.76%)
Price as of Aug 21, 2026 7:30 PM EDT- $1.3BMarket Cap
- 778.97%1-Year Change
- BiotechnologyIndustry
ALTO NEURO (ANRO)
$34.54+$0.26 (+0.76%)
ANRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $34.28 | ||
Change | +$0.03 (+0.09%) | ||
Open | $34.44 | ||
High | $35.29 | ||
Low | $33.66 | ||
Previous Close | $34.25 | ||
Volume | 291,167 | ||
30-Day Average Volume | 427,407 | ||
1-Week Change | 6.66% | ||
1-Month Change | 26.63% | ||
1-Year Change | 778.97% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 39.2M | ||
Total Assets | $254.1M | ||
Market Cap | $1.3B | ||
Enterprise Value | $1.1B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$27.6M | ||
Free Cash Flow | -$19.8M | ||
EBIT | -$27.1M | ||
EBITDA | -$27.0M | ||
Net Working Capital | $230.7M | ||
EPS | -$0.65 | ||
Enterprise Value/EBITDA | -42 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -53 | ||
PEG | -3 | ||
Price/Free Cash Flow | -68 | ||
Price/Operating Cash Flow | -68 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue